Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling by Lee, Jisun et al.
Biochem. J. (2012) 441, 523–540 (Printed in Great Britain) doi:10.1042/BJ20111451 523
REVIEW ARTICLE
Autophagy, mitochondria and oxidative stress: cross-talk and redox
signalling
Jisun LEE*†1, Samantha GIORDANO*†1 and Jianhua ZHANG*†‡2
*Center for Free Radical Biology, University of Alabama at Birmingham, 901 19th Street South, Birmingham, AL 35294, U.S.A., †Department of Pathology, University of Alabama at
Birmingham, 901 19th Street South, Birmingham, AL 35294, U.S.A., and ‡Department of Veterans Affairs, Birmingham VA Medical Center, 700 South 19th Street, Birmingham,
AL 35233, U.S.A.
Reactive oxygen and nitrogen species change cellular responses
through diverse mechanisms that are now being deﬁned. At
low levels, they are signalling molecules, and at high levels,
they damage organelles, particularly the mitochondria. Oxidative
damage and the associated mitochondrial dysfunction may result
in energy depletion, accumulation of cytotoxic mediators and cell
death. Understanding the interface between stress adaptation and
cell death then is important for understanding redox biology and
disease pathogenesis. Recent studies have found that one major
sensor of redox signalling at this switch in cellular responses
is autophagy. Autophagic activities are mediated by a complex
molecular machinery including more than 30 Atg (AuTophaGy-
related) proteins and 50 lysosomal hydrolases. Autophagosomes
form membrane structures, sequester damaged, oxidized or
dysfunctional intracellular components and organelles, and direct
them to the lysosomes for degradation. This autophagic process
is the sole known mechanism for mitochondrial turnover. It
has been speculated that dysfunction of autophagy may result
in abnormal mitochondrial function and oxidative or nitrative
stress. Emerging investigations have provided new understanding
of how autophagy of mitochondria (also known as mitophagy)
is controlled, and the impact of autophagic dysfunction on
cellular oxidative stress. The present review highlights recent
studies on redox signalling in the regulation of autophagy, in
the context of the basic mechanisms of mitophagy. Furthermore,
we discuss the impact of autophagy on mitochondrial function
and accumulation of reactive species. This is particularly relevant
to degenerative diseases in which oxidative stress occurs over
time, and dysfunction in both the mitochondrial and autophagic
pathways play a role.
Key words: autophagy, mitochondrion, neurodegeneration,
nitrative stress, oxidative stress, redox signalling.
INTRODUCTION
Autophagy (or self-eating) was ﬁrst described by Christian
de Duve in 1963 as a lysosome-mediated degradation process
for non-essential or damaged cellular constituents [1,2].
Physiologically, it serves to preserve the balance between
organelle biogenesis, protein synthesis and their clearance.
Autophagy is emerging as an important mediator of pathological
responses and engages in cross-talk with ROS (reactive oxygen
species) and RNS (reactive nitrogen species) in both cell
signalling and protein damage.
Impaired mitochondrial function, oxidative stress, accumula-
tion of protein aggregates and autophagic stress are common
in many pathologies, including neurodegenerative diseases [3,4].
Oxidative stress can lead to the non-speciﬁc post-translational
modiﬁcations of proteins and contributes to protein aggregation.
Since the brain uses 20% of the inspired oxygen and 90%
of the consumed oxygen to produce energy during oxidative
phosphorylation, it is not surprising that neuronal cells are
particularly sensitive to oxidative stress. During oxidative phos-
phorylation, neurons in the brain are vulnerable to oxidative
damage because of their high metabolic activity, low antioxidant
capacity and non-replicative nature.
The highly abundant mitochondria in brain cells are a major
site of generation and action of ROS/RNS. Speciﬁc forms of
ROS and RNS include hydrogen peroxide (H2O2), superoxide
(O2
• −), nitric oxide (NO), peroxynitrite (ONOO
−)a n dR L S
(reactive lipid species). Lipid peroxidation is a consistent feature
of neurodegenerative diseases and biologically active RLS,
such as HNE (4-hydroxynonenal), accumulates in brains of
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individualswithParkinson’sorAlzheimer’sdisease[5–10].Other
mechanisms of protein modiﬁcation are NO-dependent. For
example, NO reacts with O2
• − and generates ONOO
−,w h i c h
is capable of initiating further protein oxidation and nitration
[11,12]. The nitrogen dioxide radical, formed biologically
from the reaction of NO with oxygen or decomposition from
ONOO
−, reacts with tyrosine residues, resulting in 3-nitro-
tyrosine formation [13]. The addition of NO to thiol groups on
proteins, S-nitrosation (also referred to as S-nitrosylation), has
also been reported in neurodegenerative diseases. This adduct
has been detected in a broad range of pathologies, including
Parkinson’s disease, which is associated with both nitrated
α-synuclein and S-nitrosated parkin [14]. Likewise, ONOO
−-
dependent modiﬁcations of proteins are widespread in brains of
individuals with Alzheimer’s disease [15].
Oxidative stress is inseparably linked to mitochondrial
dysfunction, as mitochondria are both generators of and targets
for reactive species [16]. Mitochondrial turnover is dependent
on autophagy, which declines with age and is frequently
dysfunctional in neurodegenerative diseases [3]. The cross-
talk between autophagy, redox signalling and mitochondrial
dysfunctionisnotwellunderstood.Somepossibilities includethe
accumulation of toxic proteins and the decrease in mitochondrial
function, leading to further oxidative stress when the autophagic
process is disrupted [17–19]. Dysregulated redox signalling
or mitochondrial dysfunction can also inﬂuence autophagic
activities. How particular species of modiﬁed proteins participate
in the neurodegenerative process remains unclear. The present
review highlights recent studies on redox signalling in regulation
of autophagy, as well as mechanisms of mitophagy. Furthermore,
we discuss the impact of autophagy on mitochondrial function,
accumulation of ROS and relevance to chronic pathologies, with
a particular emphasis on neurodegenerative diseases.
AUTOPHAGY MECHANISMS
Autophagy machinery
Three classes of autophagy have been described, based on
how protein substrates for degradation reach the lumen of the
lysosome.
(i) Macroautophagy (generally referred to as autophagy) is a
multi-step process, involving the formation of double-membrane
vesicles known as autophagosomes. Autophagosomes mature
and fuse with lysosomes to degrade their contents in the acidic
environment mediated by acidic hydrolases. More than 30 Atg
(AuTophaGy-related) proteins conserved from yeast to mammals
participate in autophagy at different steps throughout the process
[20,21].
(ii) Microautophagy is a process in which lysosomes directly
wraparoundcytosolicconstituentsandingestcargobymembrane
involution [22–25].
(iii) Chaperone-mediated autophagy targets chaperones to
proteins that contain a motif biochemically related to the
pentapeptide KFERQ. The chaperone–KFERQ-containing
protein complex then binds LAMP (lysosome-associated
membraneprotein)-2Areceptorsonthelysosomalmembrane,and
translocates the target proteins into the lysosomes for degradation
[26].
Macroautophagy is the focus of the present review. Selective
macroautophagy and autophagy of speciﬁc organelles are subsets
of macroautophagy that depend on selective combination of
Atg proteins [20], and are speciﬁcally discussed whenever
appropriate. Figure 1 is a simpliﬁed diagram describing these
complex processes and regulation. Many of these key steps have
been shown to be modulated by ROS/RNS or their metabolites,
including lipid peroxidation products [20,24,26].
To understand the impact of ROS/RNS on autophagy, we
brieﬂy outline key elements of the molecular mechanisms and
their control. In mammalian cells, when the signalling protein
TOR (target of rapamycin) is inhibited in response to starvation,
dephosphorylation of Atg13 occurs. Dephosphorylated Atg13
associateswithandactivatesAtg1homologues{ULK[unc(unco-
ordinatedfamilymember)-51-likekinase]1and2},leadingtothe
recruitment of FIP200 (focal adhesion kinase family-interacting
protein of 200 kDa), an orthologue of yeast Atg17. The ULKs–
Atg13–FIP200 complex participates in elongation of the isolation
membrane and progression towards a complete autophagosomal
structure [20,21,27–29] (Figure 1).
Generation of the pre-autophagosomal structure requires the
beclin-1–class III PI3K (phosphoinositide 3-kinase) complex, as
well as generation and insertion of LC3 (light chain 3)-II into the
autophagosomal membrane [21]. Atg8/LC3 is a ubiquitin-like
protein and it undergoes post-translational modiﬁcations when
LC3-I becomes LC3-II [30–32]. The C-terminal ﬂanking region
of nascent LC3 (proLC3) is cleaved by Atg4, a protease, to
become LC3-I, which then has an exposed C-terminal glycine
residue. LC3-I is modiﬁed with PE (phosphatidylethanolamine)
and is now referred to as LC3-II; this step involves a
ubiquitination-like reaction mediated by Atg7 (E1-like activating
enzyme), Atg3 (E2-like conjugating enzyme) and the Atg16L
complex (E3-like ligase enzyme). First, Atg7 plays a role in
the conjugation of Atg10 to Atg12, and conjugation of Atg3
to LC3-I. Then, E2-like enzymes Atg3 and Atg10 catalyse the
conjugation of Atg5 to Atg12, and the conjugation of LC3-I to PE
to convert LC3-I into LC3-II. These conjugation processes play
an essential role in the expansion of the autophagosomes [30–
32]. Atg7, Atg3 and Atg10 use cysteine residues in their catalytic
sites to catalyse ubiquitin transfer. These proteins may then be
sensitive to redox signalling, since the thiol groups on cysteine
residues are particularly susceptible to oxidative modiﬁcations
by ROS/RNS [33]. Lipidation of LC3-I by PE enables it to be
inserted into the autophagosomal membrane. The LC3-related
molecules GABARAP [GABAA (γ-aminobutyric acid type A)-
receptor-associated protein] and GABARAPL1 (GABARAP-like
1protein)mayplaysimilarrolesintheautophagosomalexpansion
process [34]. LC3 homologues form many functional interactions
in the autophagy network [35] (Figure 1).
Fusion of autophagosomes to lysosomes may be mediated
by Rab7 and the lysosomal transmembrane protein LAMP-2
[36–39]. Degradation of autophagosomal contents requires
lysosomal proteases, such as cathepsins D, B and L [40–42].
The cathepsins are a particularly interesting class of proteases
which have different abilities to degrade modiﬁed proteins. Many
membersofthecathepsinfamilythatareimportantinregulationof
autophagy have a cysteine at the active group, which may be sus-
ceptible to oxidative modiﬁcation by metals and redox regulation
[43]. For example, cathepsin B can be inhibited by oxidized low-
densitylipoproteinwhichmaythencontributetotheaccumulation
of oxidized lipoproteins in atherosclerotic lesions [44] (Figure 1).
Tremendous progress has been made in the ﬁeld of autophagy
in terms of identiﬁcation of the molecular components involved
in the autophagy process, especially in model systems such as
yeast. Whereasthe overall mechanics of the autophagy–lysosome
pathwayarenowclear,howthesevaryindifferentcelltypesneeds
to be established. Major gaps in our knowledge in the ﬁeld now
being addressed are how the physical and functional interactions
between the autophagosomes are controlled to achieve assembly
andthesubsequentstructuralchangesneededtoengulfcargosand
fuse with lysosomes. It is also likely that the response to different
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Figure 1 Autophagy mechanisms and regulation
There are three different mechanisms of autophagy: (i) macroautophagy, the bulk degradation of cargo; (ii) microautophagy, involution of the lysosome around cargo; and (iii) chaperone-mediated
autophagy (CMA), the degradation of the tagged cargo. The autophagosome and the lysosome fuse to degrade the cargo by lysosomal acidic hydrolases, including cathepsins D, B and L.
Macroautophagy is regulated by starvation through the Atg1–Atg13 complex, which is inhibited by mTOR activation. Rapamycin or nutrient starvation causes mTOR inactivation, subsequent
Atg1–Atg13activationandactivatesmacroautophagy.Thebeclin-1–PI3Kcomplexisinvolvedinautophagosomalexpansion.3-MAinhibitsPI3Kactivity. Atg8–pro-LC3iscleavedbyAtg4,modiﬁed
by PE to become LC3-II and inserted into the autophagosomes. The puncta formed by LC3-II and the electrophoretic separation of LC3-I and LC3-II are used as a marker for autophagosomal
accumulation. RFP–GFP–LC3 (tfLC3) form puncta with both red and green ﬂuorescence in the autophagosomes, and only red puncta when the autophagosomes fuse with lysosomes where GFP is
inactivated, therefore tfLC3 is used to monitor autophagic ﬂux. The degradation rate of long-lived proteins is another method for measurement of autophagic ﬂux. p62 binds both LC3 and ubiquitin
and therefore plays a role in targeting ubiquitinated proteins to the autophagosomes. Red arrows are indicative of negative regulators of autophagy, and green arrows are indicative of positive
regulators of autophagy. Atg4 Cys81 thiol modiﬁcation is involved in starvation and H2O2-induced autophagy. S-nitrosation of IKKβ and JNK1 are involved in NO-induced inhibition of autophagy.
ROS/RNS will place distinct demands on the autophagy system,
particularly under conditions of inﬂammation, which involves the
concerted action of multiple cell types.
Regulation of autophagy
As mentioned above, mTOR (mammalian TOR) is activated in
the presence of growth factors and abundant cellular nutrients
such as amino acids. mTOR functions as an inhibitor of the
initiationstepofmacroautophagy.Undernutrient-richconditions,
mTOR is active and phosphorylates Atg13, preventing its
association with ULK and FIP200 recruitment [27,28]. During
starvation, mTOR is inhibited, resulting in the activation of
phosphatases and partial dephosphorylation of Atg13 leading
to autophagosomal formation (Figure 1). A possible mechanism
of mTOR regulation could involve the targeting of mTOR to
cellular compartments, resulting in interactions with different
populations of protein substrates [45]. For example, amino acid
availability stimulates the translocation of mTORC1 (mTOR
complex 1) to the lysosomal surface, where it associates with
its co-activator Rheb and activates mTOR activity [45,46].
Conversely, during starvation, mTOR co-localizes with LC3
after autolysosome formation, suggesting that it may regulate
autophagosome and lysosome reformation directly [45]. This
regulatory step may be subject to ROS-dependent regulation, as
mTOR oxidation results in the inhibition of its activity [47]. The
activity of the beclin-1–class III PI3K complex is regulated by
the interaction of a series of cofactors, including Atg14/Barkor
(beclin-1-associated autophagy-related key regulator), UVRAG
(UV radiation resistance-associated gene), Bif-1 (Bax-interacting
factor 1), Ambra1 (autophagy/beclin-1 regulator 1) and Rubicon
(RUN domain- and cysteine-rich domain-containing beclin-1-
interacting protein) (Figure 1). Beclin is regulated by the
transcription factor NF-κB (nuclear factor κB) [48] and K63-
linked ubiquitination [49].
The beclin-1–class III PI3K complex activity is cysteine-
rich, but the potential regulation by ROS/RNS has not
been investigated. One positive regulator of the beclin–Bcl-2
interactionintheER(endoplasmicreticulum)isNAF-1(nutrient-
deprivation autophagy factor-1), a component of the IP3 (inositol
1,4,5-trisphosphate) receptor complex, which contains a redox-
sensitive CDGSH iron–sulfur-binding domain [50]. Another
regulator of the complex is Rubicon, a negative regulator
with a candidate redox-sensing cysteine-rich domain [51]. The
multiprotein beclin-1–class III PI3K complex must be formed for
the allosteric activation of the class III PI3K Vps34 (vacuolar
protein sorting 34) to generate PI3P (phosphatidylinositol 3-
phosphate).PI3PrecruitseffectorssuchasDFCP1(doubleFYVE
domain-containing protein 1) [52–55] and WIPI (WD-repeat
protein interacting with phosphoinositides) family proteins to
mediate the vesicle nucleation and autophagosome formation
[56,57]. Additional molecules involved in macroautophagy
regulation include AMPK (5
 -AMP-activated protein kinase)
[58], DAPK (death-associated protein kinase) [59] and IP3R (IP3
receptor)[60].Exactlyhowthesemoleculesrespondtostarvation,
proteasomal dysfunction and accumulation of damaged proteins
and/or organelles is unclear, although redox regulation may be a
key component.
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Theselectivityofmacroautophagycanoccuratdifferentlevels.
‘Adaptor’ molecules, including p62/SQSTM1, have been shown
to bind to ubiquitinated proteins and target them to LC3-II, to
promote selective uptake and degradation [61,62] (Figure 1).
The LRS (LC3-recognition sequence) is in an uncharacterized
linker region between the zinc ﬁnger and UBA (ubiquitin-
associated)domainsinmurinep62.Aszincﬁngersareparticularly
susceptible to oxidative and nitrative stress, p62 may be regulated
by redox signalling [43]. NBR1 [neighbour of BRCA1 (breast
cancer early-onset 1)], is another ‘adaptor’ molecule with both a
LC3-binding domain and a ubiquitin-binding domain [63]. These
binding domains may work in concert or separately to target
mitochondria to the autophagic pathway. p62 is not required
for autophagosomal formation and overall long-lived protein
degradation, but plays a role as a speciﬁc substrate and a target-
recognition molecule for autophagy [64].
The understanding of how nutrient regulation of autophagy
regulation occurs has advanced in the last few decades,
especially at the junction of the mTOR/Atg1/Atg13 cascades.
How ROS/RNS signals and mitochondrial dysfunction regulate
autophagy has not been fully understood. Since mitochondria are
both a source and target of ROS/RNS, a major effort is needed to
determine how the organelle communicates with the lysosome
tocombatproteinoxidation,mitochondrialdamageandthemain-
tenance of mitochondrial networks through ﬁssion and fusion.
Measurement of autophagy
Deﬁning the stages of autophagy and its progress in a
tissue or cell is important for understanding its function and
regulation. Ultrastructural analysis by EM (electron microscopy)
of autophagosomes at different stages of maturation has
been the classic approach for conﬁrming autophagic activities.
EM can distinguish early autophagosomes or phagopores,
and amphisomes, from autolysosomes generated by fusion of
amphisomesorautophagosomesfusinglysosomes[2].Measuring
the long-lived protein degradation rate by pulse–chase methods is
also a commonly used complementary approach [65]. These two
methods have helped to determine autophagic pathways and time
lapses during autophagy.
Another widely used tool for measuring autophagy is based
on Atg8/LC3. As mentioned above, LC3-I undergoes post-
translational modiﬁcations by PE to become LC3-II [30–32].
LC3-I and LC3-II can be discriminated by their difference
in mobility on gel electrophoresis [30–32]. LC3-II insertion into
the autophagosomal membrane is a consistent key step in
autophagosomal formation, and its level reﬂects the relative
amount of autophagosomes in the cell. LC3-II protein can also
be visualized by immunocytochemistry as vesicular puncta when
associated with autophagosomes [30–32].
The fate of individual LC3-II molecules depends on their
localization. During recycling, LC3-II that is located on the
outer face of the autophagosome is delipidated and converted
back into the LC3-I form in cytosol; this population of LC3
is presumably reused for another round of conjugation by PE
[30–32]. In contrast, the LC3-II that localizes to the inner
autophagosome is degraded by lysosomal proteases, after the
fusion of the autophagosome with the lysosome, as part of
the normal maturation process [66]. When autophagy–lysosome
activities are highly efﬁcient, the transient increase in LC3-
II can be overlooked. The additional use of a lysosome and
autophagosomefusioninhibitor,suchaschloroquine,toblockthe
formation/degradation of the autophagolysosome is necessary in
these cases to reveal the increase in LC3-II [67].
Currently available antibodies recognize both LC3-I and LC3-
II. Under conditions of autophagosomal accumulation, immuno-
histochemistry and immunocytochemistry signals increase and
appear punctate due to increased LC3-II which is localized
to autophagic structures. Expression of exogenously introduced
GFP (green ﬂuorescent protein)-fused LC3 has provided a
convenient method for measuring autophagy both qualitatively
and quantitatively (by measuring the punctate green ﬂuorescence
in cells [32]. Transgenic mice expressing GFP–LC3 have been
used to aid autophagy studies in vivo [68]. Interpretation of these
studies needs caution, since under speciﬁc conditions, LC3 may
form protein aggregates independently of autophagy [69], bind to
the smooth ER [70] or form puncta in response to detergents [71].
The accumulation of autophagosomes may be due to increased
autophagic initiation or decreased autophagic completion. In
the latter scenario, when autophagic ﬂux is blocked, the
degradation of the inner membrane-localized LC3-II cannot
occur; and the number of LC3-positive puncta increases as a
result of the accumulation of autophagosomes. To distinguish
whether the accumulation of autophagosomes is due to
increased autophagosomal formation or decreased fusion of
autophagosomeswithlysosomes,thetfLC3(tandemﬂuorescently
tagged LC3) method has been developed [72]. This assay is based
onthesensitivityoftheﬂuorescentsignalofGFPtothelysosomal
acidic/proteolytic environment, whereas RFP (red ﬂuorescent
protein) is resistant to the acidic environment. LC3 tandemly
tagged with GFP and RFP exhibit overlapping GFP and RFP
signals in the autophagosomes before fusion with the lysosomes,
butoncethematurationtoanautolysosomeoccurs,itexhibitsonly
the RFP signal. Therefore the appearance of the puncta exhibiting
only an RFP signal indicates the normal autophagic maturation
process and ﬂux activities. This allows for a live imaging of
autophagy, unlike EM, which is in ﬁxed tissue. Transgenic mice
expressing tfLC3 have been generated to study autophagic ﬂux
in the heart, and other transgenic tfLC3 models will be extremely
important for studying many diseases [73].
Currently, multiple approaches for the measurement of
autophagy are necessary to draw conclusions regarding the status
of the autophagy process, whether activated or repressed, in
response to ROS/RNS signalling. Live-cell imaging will be very
helpful to simultaneously follow autophagosomes as they form,
move and fuse with lysosomes. This will help to determine
changes in autophagic ﬂux and to determine in real time how
ROS/RNS affect autophagic activity. The availability of domain-
speciﬁcredoxsensorsoffersaninterestingopportunitytomapthe
progression of autophagy in the cell with oxidative stress [74].
AUTOPHAGY REGULATION BY REDOX SIGNALLING
Ithaslongbeenknownthattheconditionsthatregulatetheactivity
of the autophagic process are also associated with changes in
the production of ROS/RNS in cells. As shown in Figure 2,
ROS/RNS are a range of oxygen-derived molecules formed by
the incomplete reduction of oxygen during oxidative metabolism
andhavebothspeciﬁcmechanismsofproductionandintracellular
targets.ThemostimportantbiologicallyareO2
• − andH2O2,since
bothcanbeformedbycontrolledmechanismsincellsandarecell
signallingmolecules[75].O2
• − andH2O2 caninteractwithNOto
generatenitratingspecies,suchasONOO
−,andoxidizedlipidsto
produce RLS [12,76]. A major endogenous source of both O2
• −
and H2O2 is the mETC (mitochondrial electron-transport chain),
where continuous electron leakage to O2 occurs during aerobic
respiration [16]. In addition to the mETC, low levels of ROS
are produced by membrane-localized NOXs (NADPH oxidases)
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Figure 2 ROS/RNS production and signalling
(A) ROS/RNS production and signalling of autophagy. ROS and RNS production can be induced by protein aggregates, generated by the mitochondrial respiratory activities and by other cellular
oxidases.TheseROS/RNSspeciescanmodifysignallingmoleculestostimulateorinhibitautophagy.Atg4Cys81 thiolmodiﬁcationisinvolvedinstarvationandH2O2-inducedautophagy.S-nitrosation
of IKKβ and JNK1 areinvolved in NO-inducedinhibition of autophagy.AlthoughmanyROS/RNS haveeffects on autophagy,besidesa handfulof knownROS/RNS-targeted autophagyregulators,the
exact mechanisms for the effect of ROS/RNS on autophagy are largely unknown. (B) Mitochondrial production of ROS/RNS. Regardless of their sources, H2O2 and NO can target to the mitochondria.
Mitochondrially produced superoxide (O2
• −) can react with NO to produce peroxynitrite (ONOOH). O2
• −,H 2O2 and ONOOH can further damage the mitochondria in combination with iron and
produce lipid peroxidation (LPO) products, including HNE. MnSOD, aconitase, GPX (glutathione peroxidase) and catalase are involved in generation and reduction of these products. HNE, NO
and H2O2 can modify proteins to initiate signalling mechanisms or damage. The most sensitive moieties to oxidative modiﬁcation are the thiols on cysteine residues. Redox reactions in protein
modiﬁcation are involved in signalling of autophagy.
[77], peroxisomes [78] and the cytochrome p450 system [79].
It is important to recognize that the ROS cannot be considered
as discrete or independent redox messengers since they can be
interconverted.
For example, starvation not only increases ROS levels in the
cell, but also stimulates autophagy [80,81]. Both O2
• − and H2O2
have been shown to mediate autophagy induction [80,82]. For
example, H2O2 can modify mitochondrial proteins damaging
the electron-transfer process, so that they now generate intra-
mitochondrial O2
• −. In a further example, oxidative modiﬁcation
of the NOSs (nitric oxide synthases) can cause disruption of
electron transfer within the enzymes, inhibiting the formation
ofnitricoxideandgeneratingO2
• − [83,84].Inabiologicalsetting,
itisthenlikelythatthecellisrespondingtothecombinedeffectsof
ROS/RNS acting at different sites within the autophagic process.
Mitochondria generate ROS from a number of different redox
centresintherespiratorychainandothermetabolicpathways[16].
The primary ROS generated from mitochondria is O2
• −,w h i c h
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can then be converted into other ROS such as H2O2 or ONOO
−
(Figure 2). At low levels, it is thought that mitochondrial ROS
play a role in cell signalling, but, at higher levels, mitochondrial
proteins are susceptible to damage because of the concentration
of both oxidizable lipids and abundant redox-active proteins
which can amplify oxidative damage [16,85]. It is then essential
to regulate autophagy at multiple levels, including removal of
defective proteins generating uncontrolled ROS and the entire
organelle by mitophagy. Not surprisingly, the mitochondrion and
mitochondriallyproducedROSareemergingasimportantplayers
in autophagy and mitophagy [80,86].
The reduction of superoxide and generation of H2O2
is controlled by the SODs (superoxide dismutases). The
mitochondrial form is located in the matrix and contains a
manganese prosthetic group and is known as SOD2 or MnSOD.
Mitochondrial MnSOD-deﬁcient cells exhibit decreased oxygen
consumption and increased O2
• − production, suggesting a key
role in the response to pathological stressors [87,88]. For
example, in response to acute alcohol binge in mice, MnSOD
overexpression prevents, and MnSOD deﬁciency exacerbates,
NOS expression, plasma nitrites/nitrates, nitration of complex
I and V proteins, and mtDNA (mitochondrial DNA) depletion
[89]. In a transgenic Alzheimer’s disease mouse, MnSOD
overexpression led to increased catalase protein levels, decreased
total oxidized proteins and amyloid burden, and improved
spatial memory [90]. Mutations of SOD1 or Cu,ZnSOD, the
cytoplasmic form, have been found to be involved in ALS
(amyotrophic lateral sclerosis), which is a pathology associated
with oxidative stress, mitochondrial dysfunction and intracellular
protein aggregation in degenerating motor neurons [91–95].
Accumulation of autophagosomes and p62 also occurs in motor
neurons in ALS patients’ spinal cords [96], as well as in
experimental animal models [97].
Mitochondrial ROS production and oxidation of mitochondrial
lipids have been shown to play a role in autophagy. In yeast,
rapamycin induces ROS, fatty acid modiﬁcation, autophagy and
mitophagy [98]. Resveratrol and, to a lesser extent, the soluble
antioxidant NAC (N-acetyl-L-cysteine) inhibit these effects [98].
In mammalian cells, starvation-induced autophagy is associated
withincreasedoxidativestress,andbothH2O2 andO2
• − havebeen
showntoinduceautophagy[80,82].Inadditiontomitochondrially
generated ROS, NOX activities have also been shown to play an
important role in antibacterial phagosome autophagy, neutrophil
autophagy and ER stress autophagy [99]. Below, we review the
current understanding of how different ROS/RNS are sensed by
the autophagy machinery, which is also summarized in Table 1.
Autophagy regulation by H2O2
H2O2 plays an important role in autophagy in response to
nutrient starvation, rapamycin, TNFα (tumour necrosis factor α)
[100] and NGF (nerve growth factor) deprivation [101,102].
NGF deprivation induces both early burst and late-phase
ROS accumulation [103], accompanied by autophagosome
accumulation [102]. In this study, NAC decreased both cellular
ROSproductionandautophagy,implicatingredoxthiolsignalling
as an important regulator of autophagy [102]. In Ewing sarcoma
cells, TNFα treatment in the presence of IκB (inhibitor of NF-
κB), led to increased ROS, protein oxidation and beclin-1 levels;
these effects are mimicked by exogenous H2O2 and suppressed
by the lipid radical scavenger BHA (butylated hydroxyanisole) or
BNP (N-butyl-α-phenylnitrone), or NF-κB activation of mTOR
[100,104]. These ﬁndings are consistent with H2O2 effects being
mediated through the production of RLS, which are well known
to modify proteins and change protein function.
Although the mechanisms remain unidentiﬁed, redox
modiﬁcation of transcription factors by electrophilic lipid
oxidation products may mediate the regulation of the levels of
autophagy genes, as has been shown with other redox signalling
pathways [105]. In support of speciﬁc mechanisms mediated by
redox signalling proteins, starvation-induced ROS formation has
been shown to play a key role in autophagic induction through
thiolmodiﬁcationoftheCys
81 siteofAtg4[80].Thethiolreduced
form of Atg4 enables the conversion of LC3-I into LC3-II,
lipidationandinsertionintotheautophagosome,andthenrecycles
LC3-II after the autophagosome fuses with the lysosome [80].
In vitro, Atg4 can be modiﬁed by H2O2 [80]. In vivo,i ti s
known that exogenous exposure to H2O2 induces autophagy, but
it is unknown whether autophagy is solely mediated by H2O2’s
primaryeffectsonAtg4oralsosecondaryeffectsviaanincreasein
mitochondrial O2
• − through oxidative modiﬁcation of the mETC
[16]. The thiol modiﬁcation of Atg4 is one of the few known
mechanisms of redox control of autophagy.
Autophagy regulation by mitochondrial O2
•−
Although exogenous exposure to H2O2 induces autophagy, some
evidence suggests that endogenously produced O2
• − may also
play an important role in the induction of autophagy. For
example, autophagy in response to starvation in HeLa cells
requires a mitochondria-dependent regulation of O2
• −,s i n c e
the overexpression of MnSOD decreases O2
• − and decreases
autophagy [82]. Consistent with a role of mitochondrial O2
• −,
siRNA(smallinterferingRNA)knockdownofMnSODincreased
autophagy, while raising levels of O2
• − and decreasing H2O2.
These studies indicated that O2
• − plays a pivotal role, perhaps
through its interactions with aconitase which can result in iron
release and promotion of lipid peroxidation [82] (Figure 2B). In
support of this idea, the lipid peroxidation product HNE induces
accumulation of LC3-II in vascular smooth muscle cells [106].
ThemechanismsstimulatingmitochondrialO2
• − arenotclear,but
they must be independent of class III PI3K, since the inhibitors
3-methyladenine and wortmannin did not change O2
• − or H2O2
levels [82]. Neither do the mechanisms seem to involve beclin,
since siRNA knockdown of beclin does not change O2
• − levels.
In glioma, paraquat and selenite induced O2
• − production and
autophagic cell death. Selenite-induced autophagy and cell death
has been found to be inhibited by overexpression of MnSOD and
Cu,ZnSOD, but not by catalase.
Autophagy regulation by nitric oxide (NO)
NO has a variety of effects on autophagy depending upon the
cell type. In glioma cells, when combined with hypothermia,
NO donors SNP (sodium nitroprusside), S-nitrosoglutathione or
PAPA-NONOate (propylamine propylamine NONOate) inhibit
thecompletionofautophagy,asisevidentbyLC3-IIaccumulation
[107], whereas in primary neurons, NO induces Drp1 (dynamin-
related protein 1)-mediated mitochondrial ﬁssion, which further
causes an increase in mitophagy [108]. Furthermore, in a
heart disease model, homocysteine increased mitochondrial
O2
• − and ONOO
− levels as detected by MitoSOX and
dihydrorhodamine-123. Functionally, this resulted in a decreased
oxygen consumption rate and increased accumulation of LC3-II
[109].
Molecular studies in primary cortical neurons, HeLa and
HEK (human embryonic kidney)-293 cells have shown that NO-
induced S-nitrosation of IKKβ (IκBk i n a s eβ) and JNK1 (c-Jun
N-terminal kinase 1) inhibits their activities, and the inhibition
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Table 1 Redox modiﬁcation of autophagy proteins and impact of autophagy deﬁcits on oxidative stress
Summary of the current literature on the impact of alterations of autophagy gene levels on mitochondrial function and cellular oxidative stress. Many of these observations have been mentioned in
the text. Furthermore, speciﬁc examples of protein modiﬁcations of autophagy regulatory molecules in response to ROS/RNS alterations are also listed.
Autophagy gene Impact on mitochondrial function Impact on oxidative stress Redox modiﬁcation
ULK1 ULK1 knockout results in decreased mitochondrial
clearance during reticulocyte maturation [27]
FIP200 The livers from FIP200 knockouts exhibit signiﬁcant
increase in mitochondrial mass [139]
The livers from FIP200 knockouts exhibit signiﬁcant
increase in ROS [139]
mTOR Rapamycin treatment, or siRNA knockdown of TSC2
(tuberous sclerosis complex 2), S6K1 (ribosomal S6
kinase 1), raptor (regulatory associated protein of mTOR)
or rictor (rapamycin-insensitive companion of mTOR),
lowered the mitochondrial membrane potential and
oxygen consumption [278]
NO-induced S-nitrosation of IKKβ inhibits its
activity and prevents the inactivation of TOR [110]
Atg3 Atg3−/− T-cells exhibited reduced autophagy and
expanded mitochondria [279]
Atg3−/− T-cells exhibit increased ROS production [279]
Atg4 Atg4b knockout results in decreased proteolytic processing
of LC3A, LC3B, GABARAP and Atg8L [280]. Atg4d has
an afﬁnity for damaged mitochondria in cells treated with
H2O2 [281]
Starvation and H2O2 induce Atg4 thiol modiﬁcation,
which is important for autophagy [80]
Atg5 Atg5−/− cells have deformed and dysfunctional
mitochondria [282,283]. Mitochondrial gene regulation
is signiﬁcantly altered in Atg5−/− T-cells [284].
Mitochondrial content and cross-sectional mitochondrial
surface area are increased in Atg5−/− T-cells [285]
Atg5−/− cells exhibit accumulation of ubiquitinated
proteins and accumulation of ROS [80,142,143,283].
Reduction of Atg5 and Atg10 further increases ROS in
response to starvation [81]. Genes involved in ROS
generation are signiﬁcantly altered in Atg5−/− T-cells
[284]
Atg7 Reticulocyte maturation is diminished, but not abolished in
Atg7−/− mice [286]. Atg7−/− erythrocytes accumulate
damaged mitochondria [287]. Mitochondrial content and
cross-sectional mitochondrial surface area are increased
in Atg7−/− T-cells [285]. Haemopoietic stem cells that
are Atg7-deﬁcient accumulate mitochondria with high
membrane potential [288]. Atg7−/− MEFs (mouse
embryonic ﬁbroblasts) exhibit dysfunctional
mitochondrial respiration [142]
Atg7−/− cells have increased ROS [285]. Haemopoietic
stem cells with Atg7 deﬁciency exhibit enhanced
mitochondrial superoxide accumulation [288]. p62 and
ROS are increased in Atg7−/− cells [142]
Beclin/Atg6 Apoptosis-deﬁcient Bcl-2-overexpressing iBMK
(immortalized baby mouse kidney) cells undergo
autophagy in response to stress. Abnormal mitochondria
accumulate in either Beclin+/− (Beclin
haploinsufﬁciency) or Atg5−/− animals [270]
ROS accumulate in either Beclin+/− or Atg5−/− animals
[270]
NO-induced S-nitrosation of JNK1 inhibits its
activity and prevents the release of beclin from
binding to Bcl-2 [110]
Atg8 (LC3B) In response to LPS (lipopolysaccharide), LC3B−/−
macrophages had more swollen mitochondria with
severely disrupted cristae [289]
LC3B−/− macrophages generate more superoxide [289]
Nix Decreased clearance of mitochondria in erythrocyte
maturation [290]
Parkin Parkin-deﬁcient ﬁbroblasts in Nix−/− mice exhibit altered
mitochondrial morphology and activities [240]
Parkin can be inhibited by S-nitrosation [238]
PINK1 PINK1−/− mice exhibit impaired mitochondrial respiratory
activities [241]. PINK1-deﬁcient dopaminergic neurons
accumulate fragmented mitochondria [242].
Down-regulation of PINK1 in neuroblastoma SH-SY5Y
cells induced mitochondrial fragmentation [243]
PINK1−/− mice exhibit increased sensitivity to oxidative
stress [241]. PINK1-deﬁcient dopaminergic neurons
accumulate mitochondrial superoxide [242]
DJ-1 Knockout of DJ-1 in fruitﬂies reduced the RCR (respiratory
control ratio) and mitochondrial DNA/nuclear DNA ratio
without changing membrane potential or complex I
subunit NDUFS3 [NADH dehydrogenase (ubiquinone)
1β subcomplex 8] level [244]. DJ-1−/− mice exhibit
reduced skeletal muscle ATP [244], down-regulated
UCP4 and UCP5 [245–247], and reduced mitochondrial
length and fusion rate [248]. Stable knockdown of DJ-1
in neuroblastoma cells led to a reduction in
mitochondrial membrane potential, mitochondrial
fragmentation and accumulation of LC3 around
mitochondria. Overexpression of DJ-1 protects against
rotenone-induced mitochondrial fragmentation; this
function is independent of PINK1 [248,250]
DJ-1−/− mice exhibit increased sensitivity to oxidative
stress, and increased H2O2 [245–247]. Addition of
glutathione or NAC attenuates DJ-1-deﬁciency-induced
phenotypes [248–250].
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of IKKβ and JNK1 in turn prevents the inactivation of TOR
and the release of Beclin from binding to Bcl-2. Overexpression
of NOS impairs autophagosome synthesis, therefore, in these
systems, NO appears to play an inhibitory role in autophagy
[110]. L-NAME (N
G-nitro-L-arginine methyl ester), a nitric oxide
synthase inhibitor, prevents NO inhibition of autophagy, and, in
this case, induction of autophagy is independent of effects on
TOR inhibition or Bcl-2 by NO [110].
Autophagy regulation and cross-talk with transcriptional regulation
of cellular antioxidants by redox signalling
Some of the post-translational protein modiﬁcations by ROS
and RNS have a profound biological impact on the cell,
by regulation of transcription factor activities that lead to
global gene expression changes, including those that regulate
autophagy and antioxidant defence in the cell. A prominent
redox signalling pathway responsive to ROS/RNS/RLS is the
Nrf2 (nuclear factor-erythroid 2-related factor 2)/Keap1 [Kelch-
like ECH (enoyl-CoA hydratase)-associated protein 1] pathway
[111]. Nrf2 can bind to the ARE (antioxidant-response element)
[also called ERE (electrophile-response element)] sequence to
activate transcription of antioxidant and cellular detoxiﬁcation
genes [112–115]. Interestingly, it also activates autophagy by
increasing p62, thereby enhancing the cells’ ability to process
damaged proteins, as well as scavenge reactive species which
cause protein damage. Nrf2-deﬁcient cells exhibit a deﬁcient
stress response [116]. Nrf2 is negatively regulated by the
cytoplasmic redox-sensor protein Keap1 via its Neh2 (Nrf2/ECH
homology 2) domain [117]. Cysteine residue modiﬁcations of
Keap1 release Nrf2 from binding to Keap1. These modiﬁcations
inhibit the proteasomal degradation of Nrf2 and cause the
translocation of Nrf2 to the nucleus to activate the transcription
of antioxidant genes,such as NQO1 [NAD(P)H:quinone acceptor
oxidoreductase 1] and GSTs (glutathione transferases) [118], and
the autophagy genes such as p62 [119,120]. Therefore, indirectly,
autophagy can be regulated by transcriptional mechanisms in
response to ROS/RNS.
Another transcriptional sensor of ROS, which is intimately
linked to autophagy, is p53, which is elevated in response
to ROS [121,122]. It also regulates target genes that either
promoteordecreaseROS[123–125].p53regulationofautophagy
is complex. Downstream of p53, both autophagy-attenuating
and autophagy-promoting genes have been found. One p53
target gene is the TIGAR [TP53 (tumour protein 53)-induced
glycolysisandapoptosisregulator]genewhichhasafructose-2,6-
bisphosphatase activity. TIGAR decreases glycolysis, increases
NADPH,increasestheGSH/GSSGratioandreducesp53-induced
intracellular ROS [126]. TIGAR overexpression attenuates
starvation-induced and hypoxia/glucose deprivation-induced
autophagy [81]. Another p53-regulated gene, DRAM (damage-
regulated autophagy modulator) promotes autophagy [127].
p53-regulated sestrin proteins enhance autophagy via activation
of AMPK which inhibits mTOR [128], although evidence
for whether sestrin 2 acts as a reductase of sulﬁnylated per-
oxidredoxins or has other functions is being investigated
[129,130].
AUTOPHAGY REGULATION OF ROS AND RNS
Dysregulation of autophagy leads to increases in oxidative stress,
as shown by many pharmacological inhibitor and knockout
studies (summarized in Table 1). Autophagy inhibition by the
lysosomotropic agent chloroquine or the cathepsin D inhibitor
pepstatinAincreasestheformationofreactivespecies[131–135].
Cathepsin D-knockout mice exhibit increased iNOS (inducible
NOS) and NO production [136]. Many lysosomal diseases
exhibitautophagosomalaccumulation,asindicatedbyanincrease
in LC3-II, and an accumulation of p62, a known substrate of
autophagic degradation. Among the lysosomal diseases, there are
various changes in mitochondrial morphology and mitochondrial
function, in both tissues and isolated mitochondria [137].
Furthermore, disruption of the autophagy pathway at earlier steps
also leads to accumulation of ubiquitinated proteins, increased
ROS and dysfunctional mitochondria. Genetically engineered
mousemodelshaveprovidedabundantevidencefortheimportant
role of autophagy in mitochondrial integrity, intracellular protein
clearance and ROS control. For example, AMPK- and ULK1-
(Atg1 homologue) knockout liver exhibits p62 accumulation
and defective mitophagy [138]. Downstream of Atg1, FIP200-
(Atg17 homologue) knockout livers exhibit signiﬁcant increases
in mitochondrial mass and ROS [139]. Atg5- and Atg7-knockout
miceorcellsaccumulateubiquitinatedproteinsandROS[80,140–
143]. Decreased levels of Atg5 and Atg10 further increase ROS
in response to starvation [81].
Autophagic degradation of proteins
Undernormalconditions,proteindegradationismediatedbyboth
the autophagy–lysosome pathway and the ubiquitin–proteasome
system. The ubiquitin–proteasome system is thought to be
primarily responsible for the degradation of short-lived signalling
molecules or misfolded proteins tagged with ubiquitin [144]. The
proteasome contains a 19S regulatory subunit which docks on
the α-subunit rings of the catalytically active 20S core. The 19S
regulatory particle contains ∼18 subunits, including a protein
that recognizes ubiquitinated substrates and positions them for
proteasomal degradation [145]. Numerous studies have shown
that the ubiquitin–proteasome system is one pathway through
which oxidatively modiﬁed proteins can be degraded [146–152].
Under severe stress, however, this ubiquitin–proteasome pathway
can be overwhelmed, and the autophagy–lysosome pathway is
then required to increase its activity to compensate for the
increased protein damage.
Autophagic degradation can target selective groups of proteins,
lipids and organelles, depending on not only cellular ATP, but
also the type, distribution and level of oxidative stress [29].
The pioneer studies in yeast in identiﬁcation of autophagic
process and molecular components of the autophagy–lysosome
(vacuolar)degradationmachinerylaidthefoundationforstudying
autophagic degradation of proteins and organelles in mammalian
cells. Yeast vacuolar (equivalent of mammalian lysosomes)
proteases are responsible for up to 70% of cellular protein
turnover under nutrient-deprivation conditions in response to
the sporulation signal [153]. ROS regulation of yeast autophagy
is evident by an up-regulation of yeast lysosomal cathepsin D
homologue (PEP4) in response to H2O2. PEP4-deﬁcient cells
exhibit reduced protein degradation, accumulation of oxidized
proteins and shortened lifespan [154]. A role of autophagy
in protection against accumulation of oxidized proteins is a
conserved process through evolution. Cathepsin D-deﬁcient
sheep, mice and humans exhibit accumulation of ubiquitinated
proteins and α-synuclein [41,42], indicating insufﬁcient protein
degradation.
The autophagy–lysosome pathway also degrades ubiquitinated
proteins. p62, NBR1 and NDP52 (nuclear domain 10 protein)
recognize ubiquitin moieties and target ubiquitinated proteins or
ubiquitin-coated bacteria to the autophagosomes via binding to
Atg8/LC3[62,63,155–157].Afunctionalhomologueofp62,Alfy
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(autophagy-linkedFYVEprotein)ishighlyexpressedinthebrain
andhasbeenfoundtorecognizeproteinaggregatesandbringthem
to p62, Atg5 and Vps34 [53,158,159], supporting cell-type- and
tissue-speciﬁc autophagy regulation.
When cells are subject to starvation, stress or pathological
damage, autophagy may degrade proteasomes [160]. Alternat-
ively, autophagy can compensate for deﬁciencies in proteasomal
degradation [161,162]. Deﬁcits in the autophagy pathway lead to
accumulation of ubiquitinated proteins [119,140,141,163].
The accumulation of ubiquitinated proteins in these scenarios can
be attributed to the combined consequence of lack of autophagic
ﬂux and p62 accumulation, which also inhibits protein targeting
to the proteasome [119,140,141,163]. Conversely, proteasomal
activities also play a role in regulating autophagic activities. A
recentstudyreportedthat,becauseofitsubiquitin-likedomainand
its N-terminal domain, LC3 can be degraded by the proteasome
in vitro [164]. When p62 is available to bind to LC3, this
degradation of LC3 by the proteasome can be prevented, thus
making LC3 engagement to the autophagosomes possible [164].
Another transcription factor, FOXO3 (forkhead box O3), is
activated in response to oxidative stress, and regulates the
transcription of target genes involved in both proteasomal and
autophagic activities [165,166]. Ubiquitin ligases, parkin and the
CHIP [C-terminus of Hsc70 (heat-shock cognate 70)-interacting
protein] have been shown to contribute to both proteasomal
and autophagosomal targeting of proteins and organelles [167–
170]. The relative levels of co-chaperone, BAG (Bcl-2-associated
athanogene)1andBAG3proteinsbalancethecellulardependence
on either proteasomal or autophagic activities [171–173].
It is well established that dysfunction of autophagic activities
results in accumulation of protein aggregates. However, it is not
clear how protein aggregates are recognized and targeted to the
autophagosomes.
Autophagic degradation of damaged mitochondria
Since mitochondria lack a compact chromatin structure and
have an abbreviated replication and repair system compared
with nuclear DNA, mtDNA is 10–20 times more likely to have
mutations and incurs more damage with age [174]. As mentioned
above, autophagy plays an important role in the regulation of
mitochondrial function. In normal mammalian brains, it has
been shown that mitochondria have an average half-life of
10–25 days [175]. During starvation, mitochondrial turnover can
be accelerated [160] by an autophagic process speciﬁcally called
mitophagy [176].
Mitochondrial membrane depolarization has been shown to
precede the induction of autophagy by nutrient deprivation
in hepatocytes, and the depolarized mitochondria co-localize
with autophagosomes [177]. Further studies have shown
that mitochondrial ﬁssion also co-ordinates with mitophagy
[178–180]. Mitochondria will fuse every 5–20 min to reduce
mitochondrial depolarization in both COS7 and INS1 cells
[181]. Mitochondrial remodelling through ﬁssion, fusion or mi-
tophagy is important for mitochondrial homoeostasis. In cultured
liver hepatocytes, although mitochondria undergo ﬁssion, fusion
or mitophagy, the overall mtDNA/nuclear DNA ratio remains
unchanged,implyingthatareasofthemitochondriawhichcontain
the mitochondrial genome are not degraded. This is indicative
of the speciﬁcity of ﬁssion, fusion and mitophagy [178].
Mitophagy may also be important in attenuating apoptosis or
necrosis, by clearance of damaged mitochondria. This could then
prevent the inadvertent release of cytochrome c, AIF (apoptosis-
inducing factor) and other apoptotic factors.
Mitophagy is controlled either in conjunction with general
macroautophagyorselectivelythroughspeciﬁcmitophagygenes.
AMPKisactivatedinresponsetodecreasedintracellularATPand
then phosphorylates ULK1 and ULK2 (two Atg1 homologues)
to activate both general macroautophagy and mitophagy [138].
AMPK- or ULK1-deﬁcient hepatocytes exhibit accumulation of
p62, ubiquitin aggregates and abnormal mitochondria [138]. The
selectivity of mitophagy is controlled by a variety of proteins,
including PINK1 [PTEN (phosphatase and tensin homologue
deletedonchromosome10)-inducedkinase1],parkin,BNIP(Bcl-
2/adenovirus E18 19-kDa-interacting protein) and Atg32, as well
as the processes of mitochondrial ﬁssion and fusion [168,182–
185]. The yeast mitophagy-speciﬁc protein Atg32 localizes to the
mitochondrial outer membrane, where it interacts with Atg11.
Atg11 then interacts with Atg8 (LC3) and incorporates the
mitochondria into the autophagosome [182,183]. Mitophagy
regulation by Atg32 is controlled by the phosphorylation of
Ser
114 [186]. The mammalian sequence homologue of Atg32
has not been identiﬁed, but putative functional homologues
include Nix protein, a gene disruption of which results in defects
in clearance of mitochondria in erythrocyte maturation [187],
and BNIP. Autophagy induction by BNIP in Bax/Bak double-
knockout cells is independent of UCPs (uncoupling proteins) or
the mtDNA/nuclear DNA ratio, and is protective against cell
death. BNIP overexpression in Bax/Bak double-knockout
cells increases mitochondrial protease activities, decreases
mitochondrial complex III subunit 2, complex IV subunits I
and IV, complex V α-subunit, complex II subunit 30 kDa and
complexIsubunitNDUFB8[NADHdehydrogenase(ubiquinone)
1β subcomplex 8], but has no effects on MnSOD or Tom20
[188]. It is clear that mitophagy is highly regulated, although
the exact mechanisms have not been deﬁned. Figure 3 outlines
the important events and the roles of some of the key proteins in
mitophagy.
Mitochondrial depolarization, ﬁssion and VDAC (voltage-
dependent anion channel) ubiquitination are all candidates and
are associated with mitophagy, but how these potential signals are
integratedisnotclear.Inadditiontogeneticscreeningformutants
that fail to perform mitophagy, future efforts will need to clarify
the molecular signals for mitophagy.
AUTOPHAGY IN REDOX SIGNALLING, OXIDATIVE AND NITRATIVE
STRESS IN THE CONTEXT OF DISEASE PATHOGENESIS
One of the major questions in autophagy, redox signalling,
oxidative and nitrative stress is whether autophagy regulation of
ROS/RNS levels, intracellular location and effects play different
rolesindistinctcelltypesortissuesandindifferentchronicpatho-
logies. Likewise, it is also unclear whether different cells and tis-
sues have different redox signalling mechanisms for regulation of
autophagy. Below, we discuss brieﬂy what is known in the ﬁeld
of neurodegenerative and heart diseases, atherosclerosis and
cancer.
Parkinson’s disease
Parkinson’s disease is a movement disorder manifested by
neurodegeneration of speciﬁc areas of the brain, including the
pronounced loss of substantia nigra pars compacta dopaminergic
neurons, resulting in dopamine depletion [189]. Several lines
of evidence have implicated the protein α-synuclein and
its modiﬁcation as having important roles in Parkinson’s
pathogenesis. Genetic mutations and gene ampliﬁcations of α-
synuclein are the cause of a subset of familial Parkinson’s disease
[189a]. α-Synuclein is a major component of Lewy bodies,
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Figure 3 Mitophagy
Mitophagy is the speciﬁc degradation of the mitochondria in response to global signals, including starvation and oxidative stress, or speciﬁc signals including mitochondrial targeting of signalling
proteinsormodiﬁcationofmitochondrialproteins.Inyeast,Atg32isspeciﬁcformitophagybytargetingthemitochondriatotheautophagosome.Inmammaliancells,Nixisinvolvedinmitochondrial
clearanceduringerythrocytematuration.InresponsetoreducedcellularATP,AMPKisactivatedandphosphorylatesULK1andULK2(twoAtg1homologues)toactivatebothgeneralmacroautophagy
and mitophagy. Parkinson’s disease genes encoding α-synuclein, parkin, PINK1 and DJ-1 are all involved in mitophagy. A decrease in mitochondrial membrane potential (ψm) can be induced by
ROS, and by targeting α-synuclein to the mitochondria. This decrease in mitochondrial membrane potential serves as a signal for mitophagy. In addition to a decrease in mitochondrial membrane
potential,mitochondrialﬁssionisanothersignalformitophagy.PINK1facilitatesparkintargetingtothemitochondria,andubiquitinatesthemitochondrialoutermembraneproteinVDAC.Ubiquitinated
VDAC can be recognized by p62 to initiate mitophagy. DJ-1 senses oxidative stress and serves a parallel pathway to maintain mitochondrial membrane potential and preserve mitochondria from
fragmentation. Many of the regulators of mitophagy can be regulated by ROS. For example, α-synuclein is nitrated and, as a consequence, increases its aggregation propensity. Parkin can be
sulfonated and S-nitrosated. Drp1 S-nitrosation is also involved in regulation of mitochondrial ﬁssion and associated induction of mitophagy.
which accumulate in many brain regions of both familial and
the majority of sporadic Parkinson’s disease patients depending
upon the stage of disease progression. How α-synuclein plays a
role in Parkinson’s disease pathogenesis is still under debate.
Much evidence suggests an involvement of α-synuclein in
autophagy, mitochondrial function and ROS-induced cellular
damage. α-Synuclein can be modiﬁed by nitrative stress, which
increases its propensity to aggregate [190–192]. α-Synuclein also
targets to mitochondria [193–197], where it causes a decrease
in complex I activity and/or mitochondrial damage [196,198].
This mitochondrial damage causes an increase in mitophagy,
presumably as an attempt to clear damaged mitochondria [199].
Mutations of another autosomal dominant Parkinson’s disease
gene, LRRK2 (leucine-rich repeat kinase 2), has been shown to
induce or inhibit autophagy depending on the cell type [200–
202]. LRRK2 can increase α-synuclein levels [203] and interact
with α-synuclein [204]. Furthermore, LRRK2 overexpression in
transgenic mice carrying the A53T α-synuclein transgene exhibit
accelerated neurodegeneration and α-synuclein accumulation
[205]. LRRK2-knockout mice exhibit normal substantia nigra
dopaminergic neuron histology, whereas kidneys from these mice
exhibit cell loss, accumulation and aggregation of α-synuclein
and ubiquitinated proteins, and accumulation of lipofuscin,
LC3-II and p62 [206].
That a redox imbalance is a prominent feature in brains of
individuals with Parkinson’s disease is supported by a number
of ﬁndings. Post-mortem studies have observed increased iron
levels [207–210], an early and profound loss of the antioxidant
GSH [210–212], increased lipid, protein and DNA oxidation
and/or nitration, and increased SOD2 [213–216]. Lipid peroxid-
ation products, such as HNE, accumulate in brains of individuals
with Parkinson’s disease and are known to promote autophagy
[5–10,106,217]. Oxyradical-mediated DNA damage [speciﬁcally
the production of 8-OHdG (8-hydroxydeoxyguanosine)] occurs
to a greater extent in Parkinson’s disease patients than in age-
matched controls [218]. The activity of complex I, a major
component of the mETC, is decreased in the substantia nigra
[219,220] and frontal cortex [221] in patients with Parkinson’s
disease. Mitochondrial damage or deﬁciencies can contribute to
cell death and neurodegeneration, as is evident in a variety of cell
and animal models [222–228].
Brains of individuals with Parkinson’s disease also accumulate
autophagosome-like structures, indicating autophagic stress
[229–231]. Supporting a link to pathology, it has been reported
that recessively inherited forms of Parkinson’s disease can be
caused by loss-of-function mutations in genes encoding proteins
that target to the mitochondria and mediate autophagy, including
parkin, PINK1 and DJ-1 [232,233]. Parkin is an E3 ubiquitin
ligase [168]. Some of the important parkin substrates include
VDAC [234], mitofusin assembly regulatory factor [235,236],
mitofusin1[237]andmitofusin2[237].Parkincanbeinhibitedby
S-nitrosation, which provides an important link to the generation
of RNS prevalent in neurodegenerative disease [238]. MPP
+
(1-methyl-4-phenylpyridinium ion) treatment of neuroblastoma
SH-SY5Y cells induces parkin sulfonation, decreases parkin’s E3
ligase activity and promotes subsequent self-aggregation [239].
Proteasome activities also seem to be involved in parkin-induced
mitophagy [169]. p62 has been shown to bind VDAC and both
mitofusin 1 and 2 on the mitochondria, where they are then
ubiquitinated in a parkin-mediated process, and ﬁnally destined
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formitophagicdegradation[234,237].Parkin-deﬁcientﬁbroblasts
exhibit altered mitochondrial morphology and activities [240].
Thus parkin may be both a target of RNS signalling and a
modulator of mitochondrial ROS generation.
PINK1 is present in most mitochondrial membranes, but
is usually degraded. When mitochondrial damage occurs,
PINK1 is not degraded and it recruits and phosphorylates
parkin, which initiates mitophagy [168]. PINK1-knockout
mice exhibit impaired mitochondrial respiratory activities and
increased sensitivity to oxidative stress [241]. PINK1-deﬁcient
dopaminergic neurons accumulate fragmented mitochondria
and increased mitochondrial O2
• − [242]. Down-regulation of
PINK1 in neuroblastoma SH-SY5Y cells induced mitochondrial
fragmentation and autophagy, which can be rescued by a
dominant-negative Drp1 mutant [243]. PINK1/parkin-induced
mitophagy may be mediated by VDAC and it is hypothesized
that p62 plays an important role in the eventual clearance of the
mitophagosome [234]. These observations indicate that PINK1
functions in both mitophagy and in regulating mitochondrial
generation of ROS. Whether PINK1 is a target of redox
modiﬁcation is currently unknown.
DJ-1 also plays an important role in mitochondrial integrity.
Mutant DJ-1 proteins that are associated with Parkinson’s disease
are stabilized by binding to parkin. This interaction is enhanced
further by oxidative stress [170]. DJ-1-knockout animal models
exhibit a variety of mitochondrial deﬁcits. Knockout of DJ-1
in fruitﬂies reduced the RCR (respiratory control ratio)
and mtDNA/nuclear DNA ratio, without changing membrane
potential or complex I subunit NDUFS3 [NADH dehydrogenase
(ubiquinone) Fe–S protein 3] level [244]. Mice with a DJ-1
knockout exhibit decreased skeletal muscle ATP [244], increased
sensitivity to oxidative stress, increased H2O2, down-regulated
UCP4 and UCP5 [245–247], and decreased mitochondrial length
and fusion rate [248]. These changes are also associated with
enhanced autophagic ﬂux [248,249]. Although mitochondrial
membrane potential appears to be preserved in knockout
fruitﬂies [244], stable knockdown of DJ-1 in neuroblastoma
cells led to a decrease in mitochondrial membrane potential,
increaseinmitochondrialfragmentationandaccumulationofLC3
around mitochondria. Overexpression of DJ-1 protects neuronal
cells against rotenone-induced mitochondrial fragmentation; this
function is independent of PINK1, suggesting that both PINK1
andDJ-1canindependentlyregulatemitochondrialfragmentation
[250]. Addition of glutathione or NAC, or overexpression
of parkin and PINK1, attenuates DJ-1 deﬁciency-induced
phenotypes [248–250]. This observation leads to the hypothesis
that DJ-1 is regulated by oxidative stress, although the target of
ROS is unknown [249]. Figure 3 provides a model summarizing
the involvement of parkin, PINK1 and DJ-1 in mitophagy.
Although parkin, PINK1 and DJ-1 were initially identiﬁed
as familial Parkinson’s disease genes, their involvement
in mitophagy extends beyond Parkinson’s disease. Parkin
overexpression attenuates accumulation of Aβ and deﬁcient
mitochondria in a 3×Tg Alzheimer’s disease mouse model
[251]. Also involved in mitophagy and being a potential parkin
substrate, mitochondrial ﬁssion protein Drp1 is S-nitrosated
in response also to amyloid β-peptide and is involved in
mitochondrialfragmentation[252].Mitochondrialdynamicsplay
an important role in Alzheimer’s disease. In post-mortem brains
from individuals with Alzheimer’s disease, changes in the fusion
and ﬁssion protein levels by transcriptional regulation of Drp1,
Fis1, Opa1, Mfn1 and Mfn2 have been observed [253,254].
Autophagy and mitophagy regulation are also involved in heart
diseases and cancer. We discuss these topics further in the next
section.
Cardiovascular disease
As in neurodegenerative diseases, autophagic stress occurs in
hypertension and heart failure. Basal levels of autophagy are
requiredfornormalheartfunction.ForexampleinDanondisease,
where there is a deﬁciency of LAMP-2, a protein involved
in autophagosome–lysosome fusion, there is cardioskeletal
myopathy [255–257]. In disease models, it has been shown that
autophagycanplaybothaprotectiveandadetrimentalresponseto
these pathological conditions depending on speciﬁc experimental
scenarios. Cardiac myocytes exhibit autophagy in response to
coronary occlusion [258]. In TAC (transverse aortic constriction)
models, Atg5 deﬁciency has been shown to exacerbate cell death
[259], whereas Beclin deﬁciency protected against deterioration
of cardiac function in response to TAC [258]. To interpret these
observations properly, it is important to keep in mind that some
of the autophagy inhibitors have off-target effects and some Atg
genes can have activities not directly related to autophagy. For
example, Beclin interacts with Bcl-2 and therefore may inhibit
Bcl-2 anti-apoptotic function [260]. Thus decreases in Beclin can
result in increased free Bcl-2 and therefore increase the anti-
apoptotic effects of Bcl-2 and cause increases in cell viability.
Hypoxia in rabbit hearts triggers immediate accumulation
of autophagosomes near swollen and fragmented mitochondria
[261]. Although parkin was initially identiﬁed as a familial
Parkinson’s disease gene, it has also been shown to play a
role in mitophagy in the heart. Parkin and p62 interaction
plays a key role in pre-conditioning mitophagy in the heart
[262]. Whether hypoxia increases or decreases ROS/RNS is
currently under investigation [263]. Nonetheless, loss of MnSOD
decreased mTOR signalling and increased the LC3-II/LC3-I ratio
[88]. In response to ischaemia/reperfusion, rapamycin treatment
or overexpression of Beclin, both induce autophagy and have
been shown to play a protective role [264]. Wortmannin (an
inhibitor of PI3K and autophagy), as well as Atg7 deﬁciency
have been shown to exacerbate cell death [264]. HIF-1 (hypoxia-
induciblefactor1)transcriptionregulationofantioxidantproteins
is important for signalling from ROS/RNS to the autophagy
pathway.Uponmoderatehypoxiainmouseembryonicﬁbroblasts
and a variety of human cancer cells (1–3% oxygen), HIF-1
activates the transcription of BNIP3 and BNIP3L (BNIP3-like)
(Nix) and enhances cell survival [265]. BNIP3L is present at
the outer surface of mitochondria, possesses a WXXL motif that
binds to LC3 and its homologue GABARAP [266] and thus
may be responsible for targeting mitochondria for autophagic
clearance[267].WhetherBNIP-mediatedmitophagyisprotective
or detrimental to cells may depend on cell type and age,
because of the existence of contradictory ﬁndings that have not
been resolved; for example, in an in vivo study, BNIP3 has
been shown to promote ischaemia/reperfusion-induced cardio-
myocyte cell death, and BNIP
−/− mice exhibit decreased cell
death [268].
Cancer
Autophagic activities participate in the tumorigenesis process at
several levels. First, a lack of autophagic clearance of damaged
proteins, organelles and DNA can increase mutagenesis and
lead to tumorigenesis [269]. Secondly, tumour cells probably
suffer from nutrient deprivation and hypoxia due to their highly
proliferative nature which rapidly exhausts nutrient and oxygen
supply in solid tumours. Autophagy up-regulation can provide
tumour cells with several survival advantages. It has been
shown that autophagy-deﬁcient mice are more likely to develop
tumours [143,260,270–272]. Furthermore, in response to cancer
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therapeutic agents, autophagy up-regulation may help to clear
the drug-induced damage and result in cancer cells resistant to
chemotherapy. Autophagy allows metabolites and nutrients to
be recycled and prevents the cancer cells from accumulating
dysfunctional mitochondria [273]. Autophagy inhibition in drug-
resistant cancers has been used in conjunction with other
cancertreatmentsandhascausedtumourregression.Chloroquine
potentiatedBcr/Abltyrosinekinaseinhibitor-inducedcelldeathin
chronic myeloid leukaemia primary cells and p210
BCR/ABL-
expressing myeloid precursor cells [274]. The PI3K inhibitor
3-MA (3-methyladenine) or LC3 siRNA resensitized breast
cancer cells that gained resistance to the anti-HER2 antibody
Tzb (trastuzumab) to growth inhibition by Tzb [275]. siRNA
against Beclin-1, Atg3, Atg4, Atg5 or Atg12 augmented the
effectiveness of irradiation in breast, lung and cervical squamous
cell carcinomas [276]. In these studies, it is hypothesized
that cancer cells which are autophagy-dependent are easier to
treat, since removal of autophagy will remove the cell survival
mechanisms.
Conversely, excessive autophagy can induce cell death and can
also be used as a therapeutic strategy. Autophagy has been shown
toinducecellsenescence,whichisabletostopcancerprogression
[277]. Therefore how autophagy–mitochondria function and
ROS/RNS stress can be cross-regulated will continue to be
an important topic for future investigation of mechanisms of
tumorigenesis and cancer therapy.
FUTURE DIRECTIONS AND CONCLUDING REMARKS
Autophagy is an integral biological process, important in cellular
and organismic health. Much progress has been made in
understanding the molecules involved in this complex process,
and how it is regulated. As the present review shows, a newer
hypothesis which is gaining support is that autophagic activities
aresensitivetotheROS/RNSlevels,species,andintracellularand
extracellular locations, although it is still unclear whether speciﬁc
ROS/RNS elicit speciﬁc autophagic responses.
As we have discussed, deﬁning these mechanisms is intimately
related to the issue of how and why autophagy is protective or
detrimentaltocellularhealth.Thisquestionresonateswithcurrent
controversies in the redox biology ﬁeld. The concept of oxidative
stress simply implied that ROS/RNS are toxic species because
of their highly reactive nature. Similarly, it has been suggested
that autophagy, or ‘self-eating’, is bad for the cell since it is an
unhealthy cell which has multiple vesicles. However, depending
on the particular situation, ‘self-cleansing’ can be good for the
cell. Rapid reaction of ROS/RNS can elicit rapid responses to
adapt to environmental situations. Resolving the issue of whether
autophagy damages or protects the cells, especially in response to
redox signals, will also be an area of focus for the ﬁeld.
In summary, ROS/RNS formation is part of normal cellular
physiology. Excessive or abnormal free radical production and
accumulation result in oxidative stress which is a signiﬁcant
pathology in many diseases, including neurodegenerative
diseases. Although the general inclination is to categorize
autophagy as the activity that decreases ROS/RNS damage,
experimentalproofisstilllackingregardingwhetherthisistruefor
differentspeciesofROS/RNSproducedendogenouslyatdifferent
intracellular locations. Autophagy plays an important role in
both sensing oxidative stress and removing oxidatively damaged
proteins and organelles, as well as the cellular machineries
responsible for excessive ROS/RNS production. Investigations
into the speciﬁc molecular targets of ROS in the autophagy
pathwayandthespeciﬁcsignallingmechanismswillbeimportant
for our understanding of biology and diseases.
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